Cargando…

The trans-DATA study: aims and design of a translational breast cancer prognostic marker identification study

BACKGROUND: The effect of extended adjuvant aromatase inhibition in hormone-positive breast cancer after sequential tamoxifen, aromatase inhibitor treatment of 5 years was recently investigated by the DATA study. This study found no statistically significant effect of prolonged aromatase therapy. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Ruijter, Tim C., Smits, Kim M., Aarts, Maureen J., van Hellemond, Irene E. G., Van Neste, Leander, de Vries, Bart, Peer, Petronella G. M., Veeck, Jürgen, van Engeland, Manon, Tjan-Heijnen, Vivianne C. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796450/ https://www.ncbi.nlm.nih.gov/pubmed/31641693 http://dx.doi.org/10.1186/s41512-019-0065-6

Ejemplares similares

Characteristics of triple-negative breast cancer
por: de Ruijter, Tim C., et al.
Publicado: (2010)

Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review
por: de Ruijter, Tim C., et al.
Publicado: (2020)

Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
por: van Hellemond, Irene E. G., et al.
Publicado: (2018)

Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies
por: Vriens, Birgit E.P., et al.
Publicado: (2017)

The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients
por: Vriens, Ingeborg J.H., et al.
Publicado: (2017)

A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer
por: Brandão, Rita D, et al.
Publicado: (2013)

Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers
por: Joosten, S. C., et al.
Publicado: (2021)

Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study
por: van Hellemond, Irene E.G., et al.
Publicado: (2019)

Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial
por: van Hellemond, Irene E. G., et al.
Publicado: (2020)

The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches
por: Lobbezoo, Dorien, et al.
Publicado: (2016)

Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy‐induced ovarian function failure
por: van Hellemond, Irene E.G., et al.
Publicado: (2019)

Trends in Overall Survival and Treatment Patterns in Two Large Population-Based Cohorts of Patients with Breast and Colorectal Cancer
por: van Abbema, Doris, et al.
Publicado: (2019)

Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors
por: Truin, Wilfred, et al.
Publicado: (2017)

What to Do with Non-visualized Sentinel Nodes? A Dutch Nationwide Survey Study
por: Verheuvel, Nicole C., et al.
Publicado: (2017)

Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure
por: Verheuvel, Nicole C., et al.
Publicado: (2017)

Frequency and diagnostic outcome of bilateral recall at screening mammography
por: Lameijer, Joost R. C., et al.
Publicado: (2020)

Geriatric screening tools are of limited value to predict decline in functional status and quality of life: results of a cohort study
por: Deckx, Laura, et al.
Publicado: (2015)

Epigenetic Changes in Basal Cell Carcinoma Affect SHH and WNT Signaling Components
por: Brinkhuizen, Tjinta, et al.
Publicado: (2012)

A cohort study on the evolution of psychosocial problems in older patients with breast or colorectal cancer: comparison with younger cancer patients and older primary care patients without cancer
por: Deckx, Laura, et al.
Publicado: (2015)

Patterns of treatment and outcome of ductal carcinoma in situ in the Netherlands
por: Luiten, Jacky D., et al.
Publicado: (2021)

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer
por: Vriens, B. E. P. J., et al.
Publicado: (2017)

Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands
por: Schneider, Paul Peter, et al.
Publicado: (2021)

Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium
por: Seferina, Shanly C., et al.
Publicado: (2017)

Associations of hospital volume and hospital competition with short-term, middle-term and long-term patient outcomes after breast cancer surgery: a retrospective population-based study
por: van der Schors, Wouter, et al.
Publicado: (2022)

The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer
por: Lammers, Senna W M, et al.
Publicado: (2023)

Healthcare Use during the Last Six Months of Life in Patients with Advanced Breast Cancer
por: Schmitz, Renée. S. J. M., et al.
Publicado: (2021)

Moving Breast Cancer Therapy up a Notch
por: Mollen, Erik W. J., et al.
Publicado: (2018)

Impact of the second reader on screening outcome at blinded double reading of digital screening mammograms
por: Coolen, Angela M. P., et al.
Publicado: (2018)

The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2− advanced breast cancer patients: A study of the Dutch SONABRE Registry
por: Meegdes, Marissa, et al.
Publicado: (2021)

CD44 enhances tumor aggressiveness by promoting tumor cell plasticity
por: Paulis, Yvette W.J., et al.
Publicado: (2015)

Predicting the extent of nodal involvement for node positive breast cancer patients: Development and validation of a novel tool
por: van den Hoven, Ingrid, et al.
Publicado: (2019)

Delayed breast cancer diagnosis after repeated recall at biennial screening mammography: an observational follow-up study from the Netherlands
por: Lameijer, Joost R. C., et al.
Publicado: (2020)

Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine
por: Derks, Sarah, et al.
Publicado: (2013)

SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation
por: Ruiterkamp, Jetske, et al.
Publicado: (2012)

Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE Registry
por: Claessens, Anouk K. M., et al.
Publicado: (2020)

Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer
por: Gast, Marie-Christine W., et al.
Publicado: (2011)

Stromal Expression of Hypoxia Regulated Proteins Is an Adverse Prognostic Factor in Colorectal Carcinomas
por: Cleven, Arjen H. G., et al.
Publicado: (2007)

TRAPID: an efficient online tool for the functional and comparative analysis of de novo RNA-Seq transcriptomes
por: Van Bel, Michiel, et al.
Publicado: (2013)

PubMeth: a cancer methylation database combining text-mining and expert annotation
por: Ongenaert, Maté, et al.
Publicado: (2008)

Counseling young women with early breast cancer on fertility preservation
por: ter Welle-Butalid, M. E. (Elena), et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ocn9s05judepdhl88j5uq3bom8